Profusa, Inc. 8K

Profusa, Inc. announced Q2 2026 results and multiple capital structure and operational steps, including a reverse stock split and debt-to-equity exchanges, to support closing its Option Agreement to acquire G3 Vision Labs and maintain Nasdaq listing compliance.

On August 20, 2026, Profusa, Inc. reported its second quarter 2026 financial results and provided an update on its progress toward satisfying conditions under an Option Agreement to acquire G3 Vision Labs, Inc. and its subsidiaries, including completion of a 4:1 reverse stock split effective August 18, 2026 to help meet Nasdaq listing requirements, implementation of a Certificate of Designation for Non-Voting Series A Convertible Preferred Stock, execution of $10.7 million of Series A Convertible Exchange Agreements that have already resulted in $4.57 million of debt and liabilities being exchanged into Series A Convertible Preferred Stock, borrowing $650,000 for near-term working capital, and confirmation from G3’s auditors that PCAOB-audited 2024 and 2025 financial statements are expected by mid-September, while also disclosing a Q2 2026 net loss of $8.8 million, a six‑month 2026 net loss of $12.2 million, and a transition from a stockholders’ deficit of $27.1 million at June 30, 2026 to expected stockholders’ equity of $28.4 million as of July 31, 2026 as a result of the Option Agreement.

Filing Facts

CIK

1859807

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-091905

Alert Tier

7